ONC BeOne Medicines Ltd.
$356.94▼ -3.76%
Healthcare
Other
Volume 127.0K
Avg Volume (10D) 412.4K
Key Metrics & Fundamentals
Market Cap
$40.61B
P/E Ratio
63.9
Div Yield
0.00%
52W Range
253.95 - 388.66
% vs 50 MA
2.15%
% vs 200 MA
14.34%
RSI-14
53.7
MACD Histogram
+1.4700
Beta (1Y vs SPY)
0.81
Free Cash Flow
$414.83M
Gross Rev
$1.71B
Gross Profit
$1.53B
EBITDA
$392.71M
COGS
$174.53M
Operating Exp
$1.21B
Operating Income
$325.05M
EBIT
$325.05M
Pretax Income
$312.46M
Net Income
$237.01M
EPS (Diluted)
2.08
Price & Volume History
Loading chart…
Recent News
3 Healthcare Stocks To Watch In October 2026
Simply Wall St. · Oct 24, 2026 12:09 PM ET
BeOne Medicines (ONC) Could Be 13% Undervalued As ESMO Data Lifts The Narrative
Simply Wall St. · Oct 24, 2026 10:11 AM ET
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
Business Wire · Oct 24, 2026 4:15 AM ET
BeOne Stock Tests Buy Zone With Visions Of 177% Earnings Growth. Watch This Clue.
Investor's Business Daily · Oct 23, 2026 1:50 PM ET
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
Business Wire · Oct 23, 2026 10:15 AM ET
BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 5
Business Wire · Oct 22, 2026 6:01 AM ET
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
Business Wire · Oct 19, 2026 6:00 AM ET
All You Need to Know About BeOne Medicines Ltd. - Sponsored ADR (ONC) Rating Upgrade to Strong Buy
Zacks · Oct 15, 2026 11:00 AM ET
Big Pharma Is Pouring Billions Into a New Class of ‘Protein Degrader’ Drugs
The Wall Street Journal · Oct 15, 2026 5:30 AM ET
New Strong Buy Stocks for October 15th
Zacks · Oct 15, 2026 4:02 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ONC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.